LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2025/2233 of 6 November 2025 authorising the placing on the market of Clostridium butyricum TO-A as a novel food and amending Implementing Regulation (EU) 2017/2470

Commission Implementing Regulation (EU) 2025/2233 of 6 November 2025 authorising the placing on the market of Clostridium butyricum TO-A as a novel food and amending Implementing Regulation (EU) 2017/2470

Implementing Regulation (EU) 2025/2233 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.    Clostridium butyricum TO-A is authorised to be placed on the market within the Union. Clostridium butyricum TO-A shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. 2.   The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

Only the company TOA Biopharma Co. Ltd.  ( 19 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of 5 years from 27 November 2025, unless a subsequent applicant obtains an authorisation for the novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of the company TOA Biopharma Co. Ltd.

Article 3

Open ↗

The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of 5 years from the date of entry into force of this Regulation without the agreement of the company TOA Biopharma Co. Ltd.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) In Table 1 (Authorised novel foods) the following entry is inserted: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection ‘ Clostridium butyricum TO-A Specified food category Maximum levels 1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘ Clostridium butyricum TO-A’. 2. The labelling of food supplements containing Clostridium butyricum TO-A shall bear a statement that the food supplements should not be consumed by: a) pregnant and lactating women b) infants and children under 3 years of age c) infants and children under 10 years of age d) infants and children under 14 years of age e) infants, children and adolescents under 18 years of age depending on the age group the food supplements is intended for.   Authorised on 27 November 2025. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: TOA Biopharma Co. Ltd., 2-1-11, Sasazuka, Shibuya, Tokyo, Japan. During the period of data protection, the novel food Clostridium butyricum TO-A is authorised for placing on the market within the Union only by TOA Biopharma Co. Ltd., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of TOA Biopharma Co. Ltd. End date of the data protection: 27 November 2032’ Food supplements as defined in Directive 2002/46/EC, excluding infants and young children, and pregnant and lactating women 1,0 × 10 8 CFU/day for children from 3 to < 10 years 2,0 × 10 8 CFU/day for adolescents from 10 to < 14 years 2,8 × 10 8 CFU/day for adolescents from 14 to < 18 years 3,2 × 10 8 CFU/day for adults, excluding pregnant and lactating women (2) in Table 2 (Specifications), the following entry is inserted: Authorised Novel Food Specifications ‘ Clostridium butyricum TO-A Description/Definition Clostridium butyricum TO-A, is a gram-positive, spore-forming, obligate anaerobic, non-pathogenic, non-genetically modified bacterium. The TO-A strain is deposited under number FERM BP-10866. The novel food is produced by anaerobic fermentation of Clostridium butyricum TO-A followed by centrifugation and spray-drying and mixed with potato starch (to stabilise the spores by keeping a dry environment). The novel food is a mixture of viable spores and vegetative cells with about 85 % (range: 74 %–89 %) of spores. Characteristics/criteria C. butyricum TO-A: 1-7 × 10 9 CFU/g Moisture: < 5 % Coliforms: < 10 CFU/g TAMC: ≤ 1 × 10 3 CFU/g TYMC: ≤ 1 × 10 2 CFU/g Salmonella spp.: not detected in 25 g Abbreviations: CFU, colony forming units; TAMC, total aerobic microbial count; TYMC, total yeast and mould count.’

Other acts of the same type
Commission Implementing Regulation (EU) 2025/2085 of 13 October 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories, or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birdsCommission Implementing Regulation (EU) 2025/2043 of 10 October 2025 on the structure, technical details and process for submitting evidence about the impact of climate change and the legacy effects on organic soils pursuant to Regulation (EU) 2018/841 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2045 of 10 October 2025 correcting the Slovak language version of Implementing Regulation (EU) 2019/317 laying down a performance and charging scheme in the single European skyCommission Implementing Regulation (EU) 2025/2046 of 10 October 2025 amending Implementing Regulation (EU) 2015/1486 as regards the terms of the authorisation of canthaxanthin as a feed additive for certain categories of poultry, ornamental fish and ornamental birdsCommission Implementing Regulation (EU) 2025/2048 of 10 October 2025 granting a Union authorisation for the biocidal product family 3025 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2061 of 10 October 2025 providing for emergency financial support for the agricultural sectors affected by adverse climatic events in Bulgaria, Latvia, Lithuania, Hungary, Poland and Romania, in accordance with Regulation (EU) No 1308/2013 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2027 of 9 October 2025 amending Implementing Regulation (EU) No 540/2011 as regards the approval period of the active substance penthiopyradCommission Delegated Regulation (EU) 2025/2030 of 9 October 2025 supplementing Regulation (EU) 2019/1700 of the European Parliament and of the Council by specifying the number and the title of the eight-yearly variables on work organisation and working time arrangements and on accidents at work and work-related health problems in the labour force domainCommission Implementing Regulation (EU) 2025/2034 of 9 October 2025 amending Implementing Regulation (EU) 2024/2189 as regards administrative changes to the Union authorisation for the single biocidal product ClearKlens wipes based on IPACommission Implementing Regulation (EU) 2025/2013 of 8 October 2025 making imports of terephthalic acid originating in the Republic of Korea and Mexico subject to registrationCommission Regulation (EU) 2025/2016 of 8 October 2025 correcting certain language versions of Regulation (EU) No 142/2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that DirectiveCommission Delegated Regulation (EU) 2025/2017 of 8 October 2025 amending Delegated Regulation (EU) 2016/127 as regards the protein-related requirements for infant and follow-on formula manufactured from protein hydrolysates

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next